BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38468041)

  • 1. Fractal Dimension Studies of the Brain Shape in Aging and Neurodegenerative Diseases.
    Davidson JM; Zhang L; Yue GH; Di Ieva A
    Adv Neurobiol; 2024; 36():329-363. PubMed ID: 38468041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractal dimension of the brain in neurodegenerative disease and dementia: A systematic review.
    Ziukelis ET; Mak E; Dounavi ME; Su L; T O'Brien J
    Ageing Res Rev; 2022 Aug; 79():101651. PubMed ID: 35643264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractal Dimension Analysis in Neurological Disorders: An Overview.
    Díaz Beltrán L; Madan CR; Finke C; Krohn S; Di Ieva A; Esteban FJ
    Adv Neurobiol; 2024; 36():313-328. PubMed ID: 38468040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar atrophy in neurodegeneration-a meta-analysis.
    Gellersen HM; Guo CC; O'Callaghan C; Tan RH; Sami S; Hornberger M
    J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):780-788. PubMed ID: 28501823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of grey matter degeneration in FTD patients using fractal dimension analysis.
    Sheelakumari R; Venkateswaran Rajagopalan ; Chandran A; Varghese T; Zhang L; Yue GH; Mathuranath PS; Kesavadas C
    Brain Imaging Behav; 2018 Oct; 12(5):1221-1228. PubMed ID: 29086152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray matter asymmetries in aging and neurodegeneration: A review and meta-analysis.
    Minkova L; Habich A; Peter J; Kaller CP; Eickhoff SB; Klöppel S
    Hum Brain Mapp; 2017 Dec; 38(12):5890-5904. PubMed ID: 28856766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain white matter shape changes in amyotrophic lateral sclerosis (ALS): a fractal dimension study.
    Rajagopalan V; Liu Z; Allexandre D; Zhang L; Wang XF; Pioro EP; Yue GH
    PLoS One; 2013; 8(9):e73614. PubMed ID: 24040000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Complexity of the Cerebellum and Cerebral Cortex is Reduced in Spinocerebellar Ataxia Type 2.
    Marzi C; Ciulli S; Giannelli M; Ginestroni A; Tessa C; Mascalchi M; Diciotti S
    J Neuroimaging; 2018 Nov; 28(6):688-693. PubMed ID: 29975004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging, Neurodegenerative Disorders, and Cerebellum.
    Iskusnykh IY; Zakharova AA; Kryl'skii ED; Popova TN
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer's Disease and Frontotemporal Dementia.
    Nicastro N; Malpetti M; Cope TE; Bevan-Jones WR; Mak E; Passamonti L; Rowe JB; O'Brien JT
    J Alzheimers Dis; 2020; 76(1):331-340. PubMed ID: 32444550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of nonlinear analysis indices of walking stride interval in the evaluation of neurodegenerative diseases.
    Dierick F; Vandevoorde C; Chantraine F; White O; Buisseret F
    Hum Mov Sci; 2021 Feb; 75():102741. PubMed ID: 33310379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Analysis of the Relation Between Clinical Impairment and Gray Matter Degeneration in Spinocerebellar Ataxia Type 7 Patients.
    Contreras A; Ramirez-Garcia G; Chirino A; Morgado-Valle C; Pasaye EH; Hernandez-Castillo C; Díaz R; Fernandez-Ruiz J; Beltran-Parrazal L
    Cerebellum; 2021 Jun; 20(3):346-360. PubMed ID: 33184781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
    Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington's disease patients.
    Ramirez-Garcia G; Galvez V; Diaz R; Bayliss L; Fernandez-Ruiz J; Campos-Romo A
    Eur J Neurosci; 2020 Apr; 51(8):1827-1843. PubMed ID: 31705594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractal Analysis in Neurodegenerative Diseases.
    Pirici D; Mogoanta L; Ion DA; Kumar-Singh S
    Adv Neurobiol; 2024; 36():365-384. PubMed ID: 38468042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractal dimension assessment of brain white matter structural complexity post stroke in relation to upper-extremity motor function.
    Zhang L; Butler AJ; Sun CK; Sahgal V; Wittenberg GF; Yue GH
    Brain Res; 2008 Sep; 1228():229-40. PubMed ID: 18590710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal study of the effect of a 5-year exercise intervention on structural brain complexity in older adults. A Generation 100 substudy.
    Pani J; Marzi C; Stensvold D; Wisløff U; Håberg AK; Diciotti S
    Neuroimage; 2022 Aug; 256():119226. PubMed ID: 35447353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractal dimension analysis of cerebellum in Chiari Malformation type I.
    Akar E; Kara S; Akdemir H; Kırış A
    Comput Biol Med; 2015 Sep; 64():179-86. PubMed ID: 26189156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment.
    Pantoni L; Marzi C; Poggesi A; Giorgio A; De Stefano N; Mascalchi M; Inzitari D; Salvadori E; Diciotti S
    Neuroimage Clin; 2019; 24():101990. PubMed ID: 31491677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMPARATIVE ANALYSIS OF FRACTAL DIMENSIONS OF HUMAN CEREBELLUM: IMPACT OF IMAGE PREPROCESSING AND FRACTAL ANALYSIS METHODS.
    Maryenko NI; Stepanenko OY
    Wiad Lek; 2022; 75(2):438-443. PubMed ID: 35307673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.